Skip to main content
Scholars@Duke
Menu
About
Schools / Institutes
Browse
Michael Evan Lidsky
Associate Professor of Surgery
Surgical Oncology
michael.lidsky@duke.edu
Dept of Surgery, Box 3966, Durham, NC 27710
Research
More About This Person
glance {hide_children: true, active: false, enabled: true}
At a Glance
credentials {hide_children: true, active: false, enabled: true}
Credentials
Education
Training & Certifications
academic-experience {hide_children: true, active: false, enabled: true}
Academic Experience
Current Appointments & Affiliations
Previous Appointments & Affiliations
expertise {hide_children: true, active: false, enabled: true}
Expertise
Keywords
research {hide_children: false, active: true, enabled: true}
Research
Selected Grants
publications {hide_children: true, active: false, enabled: true}
Publications
Selected Publications
artistic-works {hide_children: true, active: false, enabled: false}
Artistic Works / Events
teaching {hide_children: true, active: false, enabled: false}
Teaching
advising-mentoring {hide_children: true, active: false, enabled: false}
Advising & Mentoring
recognition {hide_children: true, active: false, enabled: false}
Recognition
professional-activities {hide_children: true, active: false, enabled: false}
Professional Activities
Manage Profile
Embed Profile Data
Manage Profile
Embed Profile Data
Selected Grants
Improving Outcome in Patients with Advanced Intrahepatic Cholangiocarcinoma: A Randomized Phase II Study of Gemcitabine and Oxaliplatin With or Without Regional Floxuridine (FUDR)
Research
Principal Investigator ·
Awarded by Memorial Sloan-Kettering Cancer Center ·
2020 - 2025
Exploitation of XLF signaling and the DNA Damage Response as a novel therapeutic strategy in cholangiocarcinoma
Research
Principal Investigator ·
Awarded by American College of Surgeons ·
2021 - 2024
Evaluation of voltage-gated calcium ion channels as a therapeutic target in intrahepatic cholangiocarcinoma
Fellowship
Mentor ·
Awarded by National Institutes of Health ·
2022 - 2024
Improving Therapeutic Efficacy and Durability in FGFR2 Fusion Positive Cholangiocarcinoma
Research
Principal Investigator ·
Awarded by The Cholangiocarcinoma Foundation ·
2022 - 2024
